Process mapping strategies to prevent subcutaneous implantable cardioverter-defibrillator infections.

ABSTRACT:

Background

Infection remains a major complication of cardiac implantable electronic devices and can lead to significant morbidity and mortality. Implantable devices that avoid transvenous leads, such as the subcutaneous implantable cardioverter-defibrillator (S-ICD), can reduce the risk of serious infection-related complications, such as bloodstream infection and infective endocarditis. While the 2017 AHA/ACC/HRS guidelines include recommendations for S-ICD use for patients at high risk of infection, currently, there are no clinical trial data that address best practices for the prevention of S-ICD infections. Therefore, an expert panel was convened to develop a consensus on these topics.

Methods

An expert process mapping methodology was used to achieve consensus on the appr

SUBMITTER: Weiss R 

PROVIDER: S-EPMC9544305 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature